The Pathophysiological Puzzle of Uremic Pruritus — Insights and Speculations from Therapeutic and Epidemiological Studies

Mettang T. , Fischer F.P. , Kuhlmann U. Urämischer Pruritus — Pathophysiologische und therapeutische Konzepte. Dtsch Med Wochenschr 1996; 121: 1025–31.

De Marchi S. , Cecchin E. , Villalta D. , Sepiacci G. , Santini G. , Bartoli E. Relief of pruritus and decreases in plasma histamine concentrations during erythropoietin therapy in patients with uremia. N Engl J Med 1992; 326: 969–74.

Balaskas E.V. , Uldall R.P. Erythropoietin does not improve uremic pruritus. Perit Dial Int 1992; 12: 330–1.

Peer G. , Kivity S. , Agami O. , Fireman E. , Silverberg D. , Blum M. Randomised crossover trial of naltrexone in uraemic pruritus. Lancet 1996; 348: 1552–4.

Pauli–Magnus C. , Mikus G. , Alscher D.M. , Kirschner T. , Nagel W. , Gugeler N. Naltrexone does not relieve uremic pruritus: Results of a randomized, placebo-controlled crossover-study. J Am Soc Nephrol 2000; 11: 514–19.

Gilchrest B.A. , Rowe J.W. , Brown R.S. , Steinman T.I. , Arndt K.A. Ultraviolet phototherapy of uremic pruritus. Long-term results and possible mechanisms of action. Ann Intern Med 1979; 91: 17–21.

Garssen J. , Vandebriel R.J. , DeGruijl F.R. , Wolvers D.A. , Van Dijk M. , Fluitman A. UVB exposure-induced systemic modulation of Th1- and Th2-mediated immune responses. Immunology 1999; 97: 506–14.

Hiroshige K. , Kabashima N. , Takasugi M. , Kuroiwa A. Optimal dialysis improves uremic pruritus. Am J Kidney Dis 1995; 25: 413–19.

Young A.W. , Sweeney E.W. , David D.S. , Cheigh J. , Hochgelerent E.L. , Sakai S. Dermatologic evaluation of pruritus in patients on hemodialysis. N Y State J Med 1973; 73: 2670–4.

Rousseau Y. , Haeffner–Cavaillon N. , Poignet J.L. , Meyrier A. , Carreno M.P. In vivo intracellular cytokine production by leukocytes during haemodialysis. Cytokine 2000; 12: 506–17.

Mettang T. , Pauli–Magnus C. , Alscher D.M. , Klumpp S. , Kuhlmann U. Short-term efficacy of tacrolimus ointment in severe uremic pruritus (Abstract). Perit Dial Int 2000; 20(Suppl 1): S60.

Silva S.R.B. , Viana P.C.F. , Lugon N.V. , Hoette M. , Ruzany F. , Lugon J.R. Thalidomide for the treatment of uremic pruritus: A crossover randomized double-blind trial. Nephron 1994; 67: 270–3.

McHugh S.M. , Rifkin I.R. , Deighton J. , Wilson A.B. , Lachmann P.J. , Lockwood C.M. The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures. Clin Exp Immunol 1995; 99: 160–7.

Suthanthiran M. , Strom T.B. Renal transplantation. N Engl J Med 1994; 331: 365–76.

Altmeyer P. , Kachel H.G. , Schäfer G. , Fassbinder W. Normalisierung der urämischen Hautveränderungen nach Nierentransplantation. Hautarzt 1986; 37: 217–21.

Call T.G. , Creagan E.T. , Frytak S. , Buckner J.C. , van Haelst–Pisani C. , Homburger H.A. Phase I trial of combined interleukin-2 with levamisole in patients with advanced malignant disease. Am J Clin Oncol 1994; 17: 344–7.

Darsow U. , Scharein E. , Bromm B. , Ring J. Skin testing of the pruritogenic activity of histamine and cytokines (interleukin-2 and tumour necrosis factor-alpha) at the dermo-epidermal junction. Br J Dermatol 1997; 137: 415–17.

Alscher D.M. , Dollenbacher U. , Pauli–Magnus C. , Machleidt C. , Kuhlmann U. , Mettang T. The stimulated INFγ and IL-10 secretion of blood mononuclear cells in patients on renal replacement therapies (RRT) show different secretion patterns. Artif Organs (in press).

Schwab M. , Mikus G. , Mettang T. , Pauli–Magnus C. , Kuhlmann U. , and Arbeitsgemeinschaft für Pädiatrische Nephrologie. Urämischer Pruritus im Kindesund Jugendalter. Monatsschr Kinderheilkd 1999; 147: 232.

Sakata–Kaneko S. , Wakatsuki Y. , Matsunaga Y. , Usui T. , Kita T. Altered Th1/Th2 commitment in human CD4+ T cells with ageing. Clin Exp Immunol 2000; 120: 267–73.